Drugs / SIR-Sphere
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01482442 Comparator | Dec 2011 → Apr 2016 | liver cancer | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SIR-Sphere | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01482442 ↗ |
| Known as | SIR-Spheres | “The SARAH trial has been designed to compare the efficacy and safety of sorafenib therapy and RE using yttrium-90 resin microspheres (SIR-Spheres™; Sirtex Medical Limited,...” PMID 25472660 ↗ Dec 2014 |